2Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for pefinatal medicine. Clin Chem. 2002,48 (12) :2097.
3Magdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic -ischemic encepholopathy after brith asphxia. Pediatr Res. 2001,49 (4) :502.
4Berger RP, Pierce MC, Wisniewski SR, et al. Neuron -specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics. 2002,109(2) :E31.
3Pierrat V, Haouariu N, Liska A, et al. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study [J]. Arch Dis Child Fetal Neonatal Ed, 2005, 90 (3) : F257-261.
4Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine [J]. Clin Chem, 2002, 48 (12) : 2097- 2104.
5Magdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic-ischemic encepholopathy after brith asphxia [J]. Pediatr Res 2001, 49 (4) : 502-506.
6Berger RP, Pierce MC, Wisniewski SR, et al. Neuron-specific enolase and S100 B in cerebro spinal fluid after severe traumatic brain in jury in infants and children [J]. Pediatrics, 2002, 109 (2) E31.
